Genetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway Are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization Analysis

0582896 - ÚEM 2024 RIV US eng J - Článek v odborném periodiku
Lu, Y. - Zhao, Y.Ch. - Chang-Claude, J. - Gruber, S.B. - Gsur, A. - Offit, K. - Vodičková, Ludmila - Woods, M.O. - Nguyen, L.H. - Wade, K.H. - Carreras-Torres, R. - Cotterchio, M. - Chan, A.T. - Phipps, A.I. - Peters, U. - Song, M.
Genetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway Are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization Analysis.
Cancer Epidemiology Biomarkers & Prevention. Roč. 32, č. 2 (2023), s. 281-286. ISSN 1055-9965. E-ISSN 1538-7755
Grant CEP: GA ČR(CZ) GA21-27902S
Institucionální podpora: RVO:68378041
Klíčová slova: short-chain fatty acids * bacterial fermentation * colon carcinogenesis * SNP´s analysis
Obor OECD: Human genetics
Impakt faktor: 3.8, rok: 2022
Způsob publikování: Open access
https://aacrjournals.org/cebp/article/32/2/281/716377/Genetic-Predictors-for-Fecal-Propionate-and

Background: Mechanistic data indicate the benefit of short-chain fatty acids (SCFA) produced by gut microbial fermentation of fiber on colorectal cancer, but direct epidemiologic evidence is limited. A recent study identified SNPs for two SCFA traits (fecal propionate and butyrate-producing microbiome pathway PWY-5022) in Europeans and showed metabolic benefits.Methods: We conducted a two-sample Mendelian randomiza-tion analysis of the genetic instruments for the two SCFA traits (three SNPs for fecal propionate and nine for PWY-5022) in relation to colorectal cancer risk in three large European genetic consortia of 58,131 colorectal cancer cases and 67,347 controls. We estimated the risk of overall colorectal cancer and conducted subgroup analyses by sex, age, and anatomic subsites of colorectal cancer.Results: We did not observe strong evidence for an association of the genetic predictors for fecal propionate levels and the abundance of PWY-5022 with the risk of overall colorectal cancer, colorectal cancer by sex, or early-onset colorectal cancer (diagnosed at <50 years), with no evidence of heterogeneity or pleiotropy. When assessed by tumor subsites, we found weak evidence for an association between PWY-5022 and risk of rectal cancer (OR per 1-SD, 0.95 , 95% confidence intervals, 0.91-0.99 , P 1/4 0.03) but it did not surpass multiple testing of subgroup analysis.Conclusions: Genetic instruments for fecal propionate levels and the abundance of PWY-5022 were not associated with colorectal cancer risk.Impact: Fecal propionate and PWY-5022 may not have a substantial influence on colorectal cancer risk. Future research is warranted to comprehensively investigate the effects of SCFA-producing bacteria and SCFAs on colorectal cancer risk.
Trvalý link: https://hdl.handle.net/11104/0350939